Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference | ||
| By: GlobeNewswire - 01 Apr 2024 | Back to overview list |
|
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in the 23rd Annual Needham Virtual Healthcare Conference being held virtually from April 8-11, 2024. Presentation Details A live webcast of the presentation will be available on the Investors section of the Company’s website. A replay of the webcast will be archived for up to 90 days following the presentation date. About Shattuck Labs, Inc. The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and of complying with disclosure obligations under Regulation FD. Investor & Media Contact: 
|
||
|
||
 | Back to overview list | |